Abstract |
We investigated the effects of chronic mineralocorticoid receptor blockade with eplerenone on the development and progression of hypertension and end organ damage in Dahl salt-sensitive rats. Eplerenone significantly attenuated the progressive rise in systolic blood pressure (SBP) (204 ± 3 vs. 179±3 mmHg, p < 0.05), reduced proteinuria (605.5 ± 29.6 vs. 479.7 ± 26.1 mg/24h, p < 0.05), improved injury scores of glomeruli, tubules, renal interstitium, and vasculature in Dahl salt-sensitive rats fed a high- salt diet. These results demonstrate that mineralocorticoid receptor antagonism provides target organ protection and attenuates the development of elevated blood pressure (BP) in a model of salt-sensitive hypertension.
|
Authors | Xiaoyan Zhou, Martin F Crook, Wanda Sharif-Rodriguez, Yonghua Zhu, Zadok Ruben, Yi Pan, Olga Urosevic-Price, Li Wang, Amy M Flattery, Gail Forrest, Daphne Szeto, Huawei Zhao, Sophie Roy, Michael J Forrest |
Journal | Clinical and experimental hypertension (New York, N.Y. : 1993)
(Clin Exp Hypertens)
Vol. 33
Issue 8
Pg. 538-47
( 2011)
ISSN: 1525-6006 [Electronic] England |
PMID | 21950654
(Publication Type: Journal Article)
|
Chemical References |
- Electrolytes
- Mineralocorticoid Receptor Antagonists
- Receptors, Mineralocorticoid
- Sodium Chloride, Dietary
- Spironolactone
- Aldosterone
- Eplerenone
- Creatinine
|
Topics |
- Aldosterone
(blood)
- Animals
- Blood Pressure
(drug effects)
- Chronic Disease
- Creatinine
(blood)
- Disease Models, Animal
- Disease Progression
- Electrolytes
(blood)
- Eplerenone
- Heart Rate
(drug effects)
- Hypertension, Renal
(drug therapy, pathology, physiopathology)
- Kidney
(drug effects, pathology, physiology)
- Male
- Mineralocorticoid Receptor Antagonists
(blood, pharmacology)
- Organ Size
- Rats
- Rats, Inbred Dahl
- Receptors, Mineralocorticoid
(physiology)
- Sodium Chloride, Dietary
(pharmacology)
- Spironolactone
(analogs & derivatives, blood, pharmacology)
|